Inhalation Sciences Sweden AB (publ) Year-End Report 2018
CEO Lena Heffler: “During the past year ISAB has passed several significant milestones. All these are clear signals that our vision – that PreciseInhale will become the standard tool for Inhalation Research and Development worldwide – is within reach”.Year-end report in brief · A credit facility was secured during the fourth quarter amounting in total to SEK 12.5m of which SEK 3.0m was drawn in December · The subsidiary Ziccum completed a listing process on Spotlight Stock Market during the fourth quarter and is thereafter an associated company of Inhalation Sciences Sweden AB, with